GSK Plc (GSK)
49.51
+0.83
(+1.70%)
USD |
NYSE |
Oct 30, 16:00
49.52
+0.01
(+0.02%)
Pre-Market: 20:00
GSK 30-Day Average Daily Volume : 5.319M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 5.319M |
| October 29, 2026 | 5.317M |
| October 28, 2026 | 5.233M |
| October 27, 2026 | 5.057M |
| October 26, 2026 | 4.989M |
| October 23, 2026 | 4.969M |
| October 22, 2026 | 4.939M |
| October 21, 2026 | 4.868M |
| October 20, 2026 | 4.828M |
| October 19, 2026 | 4.743M |
| October 16, 2026 | 4.640M |
| October 15, 2026 | 4.491M |
| October 14, 2026 | 4.384M |
| October 13, 2026 | 4.257M |
| October 12, 2026 | 4.145M |
| October 09, 2026 | 3.915M |
| October 08, 2026 | 3.712M |
| October 07, 2026 | 3.512M |
| October 06, 2026 | 3.406M |
| October 05, 2026 | 3.276M |
| October 02, 2026 | 3.240M |
| October 01, 2026 | 3.180M |
| September 30, 2026 | 3.047M |
| September 29, 2026 | 2.946M |
| September 28, 2026 | 2.944M |
| Date | Value |
|---|---|
| September 25, 2026 | 2.948M |
| September 24, 2026 | 2.927M |
| September 23, 2026 | 2.969M |
| September 22, 2026 | 2.965M |
| September 21, 2026 | 2.927M |
| September 18, 2026 | 2.915M |
| September 17, 2026 | 2.841M |
| September 16, 2026 | 2.822M |
| September 15, 2026 | 2.879M |
| September 14, 2026 | 2.939M |
| September 11, 2026 | 2.971M |
| September 10, 2026 | 3.099M |
| September 09, 2026 | 3.238M |
| September 08, 2026 | 3.434M |
| September 04, 2026 | 3.515M |
| September 03, 2026 | 3.634M |
| September 02, 2026 | 3.690M |
| September 01, 2026 | 3.725M |
| August 31, 2026 | 3.746M |
| August 28, 2026 | 3.844M |
| August 27, 2026 | 4.089M |
| August 26, 2026 | 4.139M |
| August 25, 2026 | 4.175M |
| August 24, 2026 | 4.196M |
| August 21, 2026 | 4.168M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AstraZeneca PLC | 2.950M |
| Johnson & Johnson | 7.270M |
| Eli Lilly & Co. | 2.448M |
| Merck & Co., Inc. | 9.901M |
| Novo Nordisk A/S | 13.38M |